<html>
  <head>
    <title></title>
    <!-- Licensed to: The Ideal Connection
         Document created using EDGARfilings PROfile 7.2.0.0
         Copyright 1995 - 2020 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div>
    <div style="font-weight: bold; text-align: center;">
      <hr align="center" style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; margin-left: auto; margin-right: auto;">UNITED STATES</div>
    <div style="font-weight: bold; text-align: center;">SECURITIES AND EXCHANGE COMMISSION</div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">Washington, D. C. 20549</div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">FORM 8-K</div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">CURRENT REPORT</div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;">Pursuant to Section 13 Or 15(d) of the<br>
      Securities Exchange Act of 1934</div>
    <div style="text-align: center; margin-bottom: 12pt;">Date of Report (Date of earliest event reported): December 21, 2020</div>
    <div style="text-align: center; font-weight: bold;"><u>Grow Capital, Inc.</u></div>
    <div style="text-align: center; margin-bottom: 12pt;">(Exact name of Registrant as specified in its charter)</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zd46c6ca8f7fe4b6fbb9647f9910525f2" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-right: 3.3pt; font-weight: bold;">Nevada</div>
          </td>
          <td style="width: 32.91%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center; font-weight: bold;">000-53548</div>
          </td>
          <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-weight: bold;">86-0970023</div>
          </td>
        </tr>
        <tr>
          <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(State or other Jurisdiction of Incorporation or organization)</div>
          </td>
          <td style="width: 32.91%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: center;">(Commission File Number)</div>
          </td>
          <td style="width: 33%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center;">(IRS Employer I.D. No.)</div>
          </td>
        </tr>

    </table>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;">2485 Village View Drive, Suite 180</font><br>
      <font style="font-weight: bold;">Henderson, NV 89074</font><br>
      <font style="font-weight: bold;"><u>Phone: (702) 830-7919</u></font><br>
      (Address, including zip code, and telephone number, including area code, of<br>
      registrant&#8217;s principal executive offices)</div>
    <div style="text-align: center; margin-bottom: 12pt;"><font style="font-weight: bold;"><u>N/A</u></font><br>
      (Former name, former address and former fiscal year, if changed since last report)</div>
    <div style="text-align: justify; margin-right: 3.6pt; margin-bottom: 6pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation
      of the registrant under any of the following provisions (see General Instruction A.2. below):</div>
    <div>&#9744;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
    <div>&#9744;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)</div>
    <div style="text-align: justify; margin-right: 3.6pt;">&#9744;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))</div>
    <div style="text-align: justify; margin-right: 7.2pt;">&#9744;<font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 36pt">&#160;</font>Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))</div>
    <div><br>
    </div>
    <div style="text-align: justify; margin-right: 7.2pt; margin-bottom: 6pt;">Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:</div>
    <table cellspacing="0" cellpadding="0" id="zd897395f56a845b5b26a1d4ecb8fa604" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 30.53%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; margin-right: 7.2pt; font-weight: bold;">Title of each class</div>
          </td>
          <td style="width: 29.91%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; margin-right: 7.2pt; font-weight: bold;">Trading Symbol(s)</div>
          </td>
          <td style="width: 39.57%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; margin-right: 7.2pt; font-weight: bold;">Name of each exchange on which registered</div>
          </td>
        </tr>
        <tr>
          <td style="width: 30.53%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; margin-right: 7.2pt; font-weight: bold;">None</div>
          </td>
          <td style="width: 29.91%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; margin-right: 7.2pt; font-weight: bold;">n/a</div>
          </td>
          <td style="width: 39.57%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: justify; margin-right: 7.2pt; font-weight: bold;">n/a</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; margin-right: 7.2pt; margin-bottom: 6pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405
      of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>
    <div style="text-align: justify; margin-right: 7.2pt;">Emerging growth company &#160;&#160;[X]</div>
    <div style="text-align: justify; margin-right: 7.2pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
      complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;&#160;[X]</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">1</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="margin-top: 12pt; margin-bottom: 12pt;">I<font style="font-weight: bold;">tem 8.01 Other Events</font></div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">As previously disclosed, on November 17, 2020, Grow Capital, Inc. (&#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221;
      &#8220;Grow&#8221; or the &#8220;Company&#8221;) filed a Notification of Late Filing with the Securities and Exchange Commission ("SEC') on Form 12b-25 pertaining to its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020 (the "10-Q"). Due to the
      complexity of the accounting issues arising out of businesses recently acquired, the Company was unable to timely file the 10-Q within the 5-day extension period afforded to the Company by filing the Form 12b-25.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">The Company previously anticipated filing its first quarter 10-Q prior to the 45 day cure
      period granted under OTCQB rules. However, despite the diligent efforts of its personnel, consultants and auditors, and due to the complexity of the 10-Q as previously disclosed and described below, the Company will not be able to file the 10-Q
      within the original 45 day extension of OTCQB eligibility granted by OTC. Therefore, the Company has requested an additional extension of time to complete its outstanding 10-Q which has been granted by the OTC.&#160; During this cure period, the Company
      may continue to be traded on the OTCQB market. The Company expects to file its first quarter Form 10-Q on or before February 1, 2021. <br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">As previously disclosed, our first quarter 10-Q is a complex filing because our recent
      acquisitions require us to analyze the Company&#8217;s variable interests, including equity investments, to determine if the Company has any variable interests in variable interest entities.&#160; Generally accepted accounting principles (&#8220;GAAP&#8221;) require a
      reporting entity to consolidate a variable interest entity when the reporting entity has a variable interest that provides it with a controlling interest in the variable interest entity. The entity that consolidates a variable interest entity is
      referred to as the primary beneficiary of that variable interest entity.&#160; The Company and its auditors have determined, due to the recent acquisitions, that certain additional related entities are variable interest entities of which Grow is the
      primary beneficiary, and therefore GAAP requires the consolidation of the variable interest entities with the financial statements of Grow.</div>
    <div style="text-align: justify; text-indent: 36pt; margin-top: 12pt; margin-bottom: 12pt; font-family: 'Times New Roman',Times,serif;">The Company has been diligently working with its reporting consultants and auditors to
      obtain all the required supporting data and process the very large amount of financial information. Due to several factors including the sheer volume of the information required to be analyzed and the timeline it is taking to obtain all necessary
      support from much larger operating entities, further complicated by&#160; the impact of COVID-19 on the Company the Company requested an additional thirty (30) day extension of OTC eligibility in which to complete the necessary data analysis and file the
      pending report on Form 10-Q and Form 8-K which has been granted by the OTC.&#160; The Company has been assured by its consultants, auditors and relevant personnel that this work will be completed in time to enable the filing of the delinquent 10-Q for the
      three months ended September 30, 2020 by January 31, 2021.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; margin-bottom: 12pt; font-weight: bold;"><a name="z_Aci_Pg2"></a>SIGNATURE PAGE</div>
    <div style="margin-bottom: 12pt;">Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its
      behalf by the undersigned hereunto duly authorized.</div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
    <div style="margin-left: 261pt; margin-bottom: 12pt; font-weight: bold;">Grow Capital, Inc.</div>
    <div><br>
    </div>
    <div style="margin-left: 261.35pt;">By: <u>/s/ Terry Kennedy</u><font id="TRGRRTFtoHTMLTab" style="display: inline-block; text-indent: 0px; font-size: 1px; width: 12pt">&#160;</font></div>
    <div style="margin-left: 279pt; margin-bottom: 12pt;">Terry Kennedy<br>
      Chief Executive Officer</div>
    <div style="margin-bottom: 12pt;">Dated: December 21, 2020</div>
    <div style="margin-bottom: 12pt;"><br>
    </div>
  </div>
  <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-size: 8pt; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
</body>
</html>
[{"type": "8-K", "sequence": "1", "filename": "form8k.htm", "description": "8-K", "secsgml_size_bytes": 13856}]
{"company-data": {"conformed-name": "GROW CAPITAL, INC.", "cik": "0001448558", "assigned-sic": "7371", "irs-number": "860970023", "state-of-incorporation": "NV", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-53548", "film-number": "201405159"}, "business-address": {"street1": "2485 VILLAGE VIEW DRIVE, SUITE 180", "city": "HENDERSON", "state": "NV", "zip": "89074", "phone": "541-879-0504"}, "mail-address": {"street1": "2485 VILLAGE VIEW DRIVE, SUITE 180", "city": "HENDERSON", "state": "NV", "zip": "89074"}, "former-company": [{"former-conformed-name": "GROW CONDOS, INC.", "date-changed": "20141112"}, {"former-conformed-name": "CALIBRUS, INC.", "date-changed": "20081023"}]}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 Or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 21, 2020
Grow Capital, Inc.
(Exact name of Registrant as specified in its charter)
Nevada
000-53548
86-0970023
(State or other Jurisdiction of Incorporation or organization)
(Commission File Number)
(IRS Employer I.D. No.)
2485 Village View Drive, Suite 180
Henderson, NV 89074
Phone: (702) 830-7919
(Address, including zip code, and telephone number, including area code, of
registrant's principal executive offices)
N/A
(Former name, former address and former fiscal year, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation
      of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule l 4a- l 2 under the Exchange Act ( 17 CFR 240. l 4a- l 2)
☐
Pre-commencement communications pursuant to Rule l 4d-2(b) under the Exchange Act (17 CFR 240. l 4d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240. l 3e-4(c))
Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
None
n/a
n/a
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405
      of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company   [X]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
      complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [X]
1
I
tem 8.01 Other Events
As previously disclosed, on November 17, 2020, Grow Capital, Inc. ("we," "us," "our,"
      "Grow" or the "Company") filed a Notification of Late Filing with the Securities and Exchange Commission ("SEC') on Form 12b-25 pertaining to its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2020 (the "10-Q"). Due to the
      complexity of the accounting issues arising out of businesses recently acquired, the Company was unable to timely file the 10-Q within the 5-day extension period afforded to the Company by filing the Form 12b-25.
The Company previously anticipated filing its first quarter 10-Q prior to the 45 day cure
      period granted under OTCQB rules. However, despite the diligent efforts of its personnel, consultants and auditors, and due to the complexity of the 10-Q as previously disclosed and described below, the Company will not be able to file the 10-Q
      within the original 45 day extension of OTCQB eligibility granted by OTC. Therefore, the Company has requested an additional extension of time to complete its outstanding 10-Q which has been granted by the OTC.  During this cure period, the Company
      may continue to be traded on the OTCQB market. The Company expects to file its first quarter Form 10-Q on or before February 1, 2021.
As previously disclosed, our first quarter 10-Q is a complex filing because our recent
      acquisitions require us to analyze the Company's variable interests, including equity investments, to determine if the Company has any variable interests in variable interest entities.  Generally accepted accounting principles ("GAAP") require a
      reporting entity to consolidate a variable interest entity when the reporting entity has a variable interest that provides it with a controlling interest in the variable interest entity. The entity that consolidates a variable interest entity is
      referred to as the primary beneficiary of that variable interest entity.  The Company and its auditors have determined, due to the recent acquisitions, that certain additional related entities are variable interest entities of which Grow is the
      primary beneficiary, and therefore GAAP requires the consolidation of the variable interest entities with the financial statements of Grow.
The Company has been diligently working with its reporting consultants and auditors to
      obtain all the required supporting data and process the very large amount of financial information. Due to several factors including the sheer volume of the information required to be analyzed and the timeline it is taking to obtain all necessary
      support from much larger operating entities, further complicated by  the impact of COVID-19 on the Company the Company requested an additional thirty (30) day extension of OTC eligibility in which to complete the necessary data analysis and file the
      pending report on Form 10-Q and Form 8-K which has been granted by the OTC.  The Company has been assured by its consultants, auditors and relevant personnel that this work will be completed in time to enable the filing of the delinquent 10-Q for the
      three months ended September 30, 2020 by January 31, 2021.
2
SIGNATURE PAGE
Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its
      behalf by the undersigned hereunto duly authorized.
Grow Capital, Inc.
By:
/s/ Terry Kennedy
Terry Kennedy
Chief Executive Officer
Dated: December 21, 2020
3